Device Trial Radar · NCT02996136
Assessment of the Clinical Performance of the ARROW-FLU System
Last checked: Nov 20, 2026Latest source record: Dec 19, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
3,000
Planned (sponsor's estimate)
Start
Dec 2016
Primary completion
Apr 2017
Study completion Apr 2017
Sponsor
- Lead sponsor
- Sekisui Diagnostics, LLCNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Beaufort CRO
- First posted
- Dec 19, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The ARROW-FLU Influenza A\&B Test is an in vitro diagnostic immuno-chromatographic assay intended for the qualitative detection of influenza A and influenza B viral nucleoprotein antigens from nasal or nasopharyngeal swab specimens in symptomatic patients. It is intended to aid in the rapid differential diagnosis of influenza A and/or B viral infections. This test is not intended for the detection of influenza C viruses. A negative test is presumptive and it is recommended these results be confirmed by cell culture of an FDA cleared molecular device. Negative results do not preclude influenza virus infection and should not be used as the sole basis for treatment or other management decisions.
Conditions
- Influenza, Human
Interventions
Flu SymptomsDevice
Flu Symptoms
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance of the ARROW-FLU Influenza TestTime frame: Through study completion, an average of 5 months
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Applied Research Center of Arkansas
Little Rock, Arkansas
Clinical Research of South Florida
Coral Gables, Florida
Sunrise Medical Research
Lauderdale Lakes, Florida
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.